2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
22
Neoplasm Metastasis
15
Carcinoma, Non-Small-Cell Lung
7
Glioblastoma
6
Colorectal Neoplasms
5
Triple Negative Breast Neoplasms
4
Recurrence
4
Ovarian Neoplasms
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Endometrial Neoplasms
4
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
Lung Neoplasms
3
Hereditary Sensory and Autonomic Neuropathies
3
Head and Neck Neoplasms
3
Solid Tumors
2
Melanoma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Esophageal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Treatment for Metastatic or Locally Advanced Cervical Cancer
1
Tongue Neoplasms
1
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
6
pimonidazole
4
fluoroazomycin arabinoside
4
TH 302
4
Radiotherapy
4
Propofol
3
Injections
3
Positron Emission Tomography Computed Tomography
2
Drug Therapy
2
Blood Specimen Collection
2
Bacterial Load
2
pomalidomide
1
pembrolizumab
1
inositol trispyrophosphate
1
gadobutrol
1
fluoromisonidazole
1
fludarabine
1
alovudine
1
Tirapazamine
1
Thoracotomy
1
Thoracic Surgery, Video-Assisted
1
Temozolomide
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Sevoflurane
1
Saline Solution
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Oxygen
1
Nitroglycerin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypoxia
×
NVP-BKM120
×
Clear all
NCT02128724
2019-08-01
BKM120
University of Oxford
Phase 1
Completed
21 enrolled
23 charts